Financhill
Back

Swedish Orphan Biovitrum AB Quote, Financials, Valuation and Earnings

Better Than Oil Stocks

CLICK HERE TO FIND OUT MORE
Buy
55

BIOVF
Swedish Orphan Biovitrum AB

Last Price:
28.62
Seasonality Move:
5.27%

7 Day Trial

ALL ACCESS PASS

$ 7

Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!

Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)

Swedish Orphan Biovitrum AB Price Quote

$28.62
0.00 (2.43%)
(Updated: December 11, 2024 at 5:07 AM ET)

Swedish Orphan Biovitrum AB Key Stats

Buy
55
Swedish Orphan Biovitrum AB (BIOVF) is a Buy

Day range:
$28.62 - $28.62
52-week range:
$22.40 - $32.25
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%

Volume:
450
Avg. volume:
69
1-year change:
22.57%
Market cap:
$8.5B
Revenue:
$1.9B
EPS:
$0.82

How Much Does Swedish Orphan Biovitrum AB Make?

Is Swedish Orphan Biovitrum AB Growing As A Company?

Swedish Orphan Biovitrum AB Stock Price Performance

What Is Swedish Orphan Biovitrum AB 52-Week High & Low?

Swedish Orphan Biovitrum AB Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Swedish Orphan Biovitrum AB?

Is Swedish Orphan Biovitrum AB Cash Flow Positive?

  • What Is BIOVF Cash Flow From Operations?
    Cash flow from operations (TTM) is $489.7M
  • What Is Swedish Orphan Biovitrum AB’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $1.6B
  • What Is Swedish Orphan Biovitrum AB’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$2.1B

Swedish Orphan Biovitrum AB Return On Invested Capital

  • Is Management Doing A Good Job?
    BIOVF return on invested capital is 7.99%
  • What Is Swedish Orphan Biovitrum AB Return On Assets?
    ROA measures how assets are converting to revenues and is 5.58%
  • What Is BIOVF Return On Equity?
    ROE is a measure of profitability and is 11.87%

Swedish Orphan Biovitrum AB Earnings Date & Stock Price

Swedish Orphan Biovitrum AB Competitors

Swedish Orphan Biovitrum AB Dividend Yield

Swedish Orphan Biovitrum AB Analyst Estimates

YoY Growth Past Surprise
EPS: -19.87% 0%
Revenue: 17.06% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

  • How many BIOVF shares are owned by institutional investors?
    77.1M BIOVF shares are owned by institutional investors
  • How many BIOVF shares are owned by insiders?
    0 BIOVF shares are owned by insiders